BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 16923174)

  • 1. In vivo detection of Egr2 binding to target genes during peripheral nerve myelination.
    Jang SW; LeBlanc SE; Roopra A; Wrabetz L; Svaren J
    J Neurochem; 2006 Sep; 98(5):1678-87. PubMed ID: 16923174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Locus-wide identification of Egr2/Krox20 regulatory targets in myelin genes.
    Jang SW; Srinivasan R; Jones EA; Sun G; Keles S; Krueger C; Chang LW; Nagarajan R; Svaren J
    J Neurochem; 2010 Dec; 115(6):1409-20. PubMed ID: 21044070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct regulation of myelin protein zero expression by the Egr2 transactivator.
    LeBlanc SE; Jang SW; Ward RM; Wrabetz L; Svaren J
    J Biol Chem; 2006 Mar; 281(9):5453-60. PubMed ID: 16373334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the PMP22 gene through an intronic enhancer.
    Jones EA; Lopez-Anido C; Srinivasan R; Krueger C; Chang LW; Nagarajan R; Svaren J
    J Neurosci; 2011 Mar; 31(11):4242-50. PubMed ID: 21411665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide analysis of EGR2/SOX10 binding in myelinating peripheral nerve.
    Srinivasan R; Sun G; Keles S; Jones EA; Jang SW; Krueger C; Moran JJ; Svaren J
    Nucleic Acids Res; 2012 Aug; 40(14):6449-60. PubMed ID: 22492709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EGR2 mutations in inherited neuropathies dominant-negatively inhibit myelin gene expression.
    Nagarajan R; Svaren J; Le N; Araki T; Watson M; Milbrandt J
    Neuron; 2001 May; 30(2):355-68. PubMed ID: 11394999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active gene repression by the Egr2.NAB complex during peripheral nerve myelination.
    Mager GM; Ward RM; Srinivasan R; Jang SW; Wrabetz L; Svaren J
    J Biol Chem; 2008 Jun; 283(26):18187-97. PubMed ID: 18456662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic regulation of Schwann cell enhancers after peripheral nerve injury.
    Hung HA; Sun G; Keles S; Svaren J
    J Biol Chem; 2015 Mar; 290(11):6937-50. PubMed ID: 25614629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropathy-associated Egr2 mutants disrupt cooperative activation of myelin protein zero by Egr2 and Sox10.
    LeBlanc SE; Ward RM; Svaren J
    Mol Cell Biol; 2007 May; 27(9):3521-9. PubMed ID: 17325040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of myelin protein zero by early growth response 2 through upstream and intragenic elements.
    Jang SW; Svaren J
    J Biol Chem; 2009 Jul; 284(30):20111-20. PubMed ID: 19487693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of cholesterol/lipid biosynthetic genes by Egr2/Krox20 during peripheral nerve myelination.
    Leblanc SE; Srinivasan R; Ferri C; Mager GM; Gillian-Daniel AL; Wrabetz L; Svaren J
    J Neurochem; 2005 May; 93(3):737-48. PubMed ID: 15836632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tead1 regulates the expression of Peripheral Myelin Protein 22 during Schwann cell development.
    Lopez-Anido C; Poitelon Y; Gopinath C; Moran JJ; Ma KH; Law WD; Antonellis A; Feltri ML; Svaren J
    Hum Mol Genet; 2016 Jul; 25(14):3055-3069. PubMed ID: 27288457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoic acid regulates myelin formation in the peripheral nervous system.
    Latasa MJ; Ituero M; Moran-Gonzalez A; Aranda A; Cosgaya JM
    Glia; 2010 Sep; 58(12):1451-64. PubMed ID: 20648638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of peripheral nerve expression profiles identifies a novel myelin glycoprotein, MP11.
    Ryu EJ; Yang M; Gustin JA; Chang LW; Freimuth RR; Nagarajan R; Milbrandt J
    J Neurosci; 2008 Jul; 28(30):7563-73. PubMed ID: 18650334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COUP-TFII plays a role in cAMP-induced Schwann cell differentiation and in vitro myelination by up-regulating Krox20.
    Han SH; Kim YH; Park SJ; Cho JG; Shin YK; Hong YB; Yun J; Han JY; Park HT; Park JI
    J Neurochem; 2023 Jun; 165(5):660-681. PubMed ID: 36648143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential regulation of NAB corepressor genes in Schwann cells.
    Srinivasan R; Jang SW; Ward RM; Sachdev S; Ezashi T; Svaren J
    BMC Mol Biol; 2007 Dec; 8():117. PubMed ID: 18096076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs 93-5p, 106b-5p, 17-5p, and 140-5p target the expression of early growth response protein 2 in Schwann cells.
    Sohn EJ; Nam YK; Park HT
    Neuroreport; 2019 Feb; 30(3):241-246. PubMed ID: 30614908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of Krox20 gene expression by Sox10 in myelinating Schwann cells.
    Reiprich S; Kriesch J; Schreiner S; Wegner M
    J Neurochem; 2010 Feb; 112(3):744-54. PubMed ID: 19922439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of Peripheral Nerve Myelin Maintenance by Gene Repression through Polycomb Repressive Complex 2.
    Ma KH; Hung HA; Srinivasan R; Xie H; Orkin SH; Svaren J
    J Neurosci; 2015 Jun; 35(22):8640-52. PubMed ID: 26041929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CTCF-mediated chromatin looping in EGR2 regulation and SUZ12 recruitment critical for peripheral myelination and repair.
    Wang J; Wang J; Yang L; Zhao C; Wu LN; Xu L; Zhang F; Weng Q; Wegner M; Lu QR
    Nat Commun; 2020 Aug; 11(1):4133. PubMed ID: 32807777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.